![Ryan Asay](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Ryan Asay worked as a Director of Investor Relations at Bristol Myers Squibb Co. He then worked as the Head of Investor Relations at Spark Therapeutics, Inc. from 2017 to 2020.
From 2020 to 2024, he worked as the Vice President and Head of Corporate Affairs at Mirati Therapeutics, Inc.
Anciens postes connus de Ryan Asay
| Sociétés | Poste | Fin |
|---|---|---|
| MIRATI THERAPEUTICS | Corporate Officer/Principal | 23/01/2024 |
| SPARK THERAPEUTICS, INC. | Investor Relations Contact | 01/02/2020 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
59
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
